Drug Discount Program: Status of Agency Efforts to Improve 340B Program Oversight
Testimony before the Committee on Health, Education, Labor,
and Pensions, U.S. Senate, describing the Health Resources
and Services Administration's (HRSA) actions in response to
the Government Accountability Office's (GAO)
recommendations to improve the 340B program oversight.
Covers GAO's ongoing work related to the 340B program and
HRSA's efforts to implement the GAO's recommendations.
includes information on 340B program participants, program
structure, operation, and key requirements.
Government Accountability Office
Pharmacy and prescription drugs · Policy